ROUTT DIALYSIS LLC SOS Verified
10085 DOUBLE R BLVD STE 160, RENO, NV 89521
NPI Number
1417197195
Practice location · View on Google Maps
SOS Verification: Verified
Entity Name: ROUTT DIALYSIS, LLC
Entity Number: E0728082008-9
Entity Type: Foreign Limited-Liability Company
Entity Status: Active
Formation Date: 2008-11-21
Name Match: 95%
Registered Agent
Name: CORPORATION SERVICE COMPANY*
Type: Commercial Registered Agent
Address: 112 NORTH CURRY STREET, Carson City, NV, 89703
Officers / Principals
| Title | Name | Address | Status |
|---|---|---|---|
| Mmember | Renal Treatment Centers - West, Inc. | 2000 16TH ST, JLD SECGOVFIN, Denver, CO | Active |
Total Medicaid Payments
$3,258,811
-7% vs specialty average
Patients Seen
12,989
Total Claims
134,036
$ Per Patient
$251
Specialty avg: $170
Specialty Rank
#22 of 52
Clinic/Center, End-Stage Renal Disease (ESRD) Treatment providers in Nevada
Peer Average
$3,517,617
Average total for Clinic/Center, End-Stage Renal Disease (ESRD) Treatment
Claims per Patient
10.3
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $550,011 | |
| 2019 | $560,681 | |
| 2020 | $621,834 | |
| 2021 | $462,746 | |
| 2022 | $475,501 | |
| 2023 | $278,237 | |
| 2024 | $309,801 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 90999 | Dialysis or kidney treatment — other related procedure | 45,559 | $3,258,811 | 100.0% | $72 |
| 82306 | Vitamin D blood test | 292 | $0 | 0.0% | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 10,407 | $0 | 0.0% | $0 |
| 83540 | Iron blood test | 1,330 | $0 | 0.0% | $0 |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,280 | $0 | 0.0% | $0 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc) | 327 | $0 | 0.0% | $0 |
| 83970 | Blood chemistry test (checking specific substances in your blood) | 1,607 | $0 | 0.0% | $0 |
| A4657 | Syringe, with or without needle, each | 2,979 | $0 | 0.0% | $0 |
| 85041 | Blood cell or clotting test | 1,866 | $0 | 0.0% | $0 |
| G0008 | Administration of influenza virus vaccine | 124 | $0 | 0.0% | $0 |
| Q4081 | Injection, epoetin alfa, 100 units (for end-stage kidney disease on dialysis) | 41,645 | $0 | 0.0% | $0 |
| 82728 | Blood chemistry test (checking specific substances in your blood) | 1,325 | $0 | 0.0% | $0 |
| 83550 | Iron binding capacity test | 1,331 | $0 | 0.0% | $0 |
| 85048 | Blood cell or clotting test | 1,848 | $0 | 0.0% | $0 |
| 90674 | Flu vaccine — standard injection | 44 | $0 | 0.0% | $0 |
| J0604 | Cinacalcet, oral, 1 mg, (for end-stage kidney disease on dialysis) | 72 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.